Patent applications and USPTO patent grants for BLEND THERAPEUTICS, INC..The latest application filed is for "sstr-targeted conjugates encapsulated in particles and formulations thereof".
Patent | Date |
---|---|
Sstr-targeted Conjugates Encapsulated In Particles And Formulations Thereof App 20160074526 - Bilodeau; Mark T. ;   et al. | 2016-03-17 |
Platinum Compounds, Compositions, And Uses Thereof App 20160068557 - Bilodeau; Mark T. ;   et al. | 2016-03-10 |
Compounds, Compositions, And Methods For The Treatment Of Cancers App 20150344511 - Bilodeau; Mark T. ;   et al. | 2015-12-03 |
Targeted Conjugates Encapsulated in Particles and Formulations Thereof App 20140187501 - Bilodeau; Mark T. ;   et al. | 2014-07-03 |
NCAGE Code | 6KSF6 | BLEND THERAPEUTICS, INC. |
CAGE Code | 6KSF6 | BLEND THERAPEUTICS, INC. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.